Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.19 -0.25 (-1.22%)
At close: Oct 21, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Current Leases (2011 - 2012)

Updated

Acadia Pharmaceuticals' Current Leases was $3,000 in Q3 2012, down 76.9% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Current Leases (2011 - 2012) Analysis & Trends

At the end of FY2011, Current Leases at Acadia Pharmaceuticals came in at $32,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Acadia Pharmaceuticals 3.47 Bn -4.91 Mn 279.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 3,000.00
Jun 30, 2012 13,000.00
Dec 31, 2011 32,000.00
API Access

Acadia Pharmaceuticals Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ACAD&period=max&api_key=YOUR_API_KEY